Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial
Titel:
Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial
Auteur:
Fizazi, Karim Faivre, Laura Lesaunier, François Delva, Remy Gravis, Gwenaëlle Rolland, Frédéric Priou, Frank Ferrero, Jean-Marc Houede, Nadine Mourey, Loïc Theodore, Christine Krakowski, Ivan Berdah, Jean-François Baciuchka, Marjorie Laguerre, Brigitte Fléchon, Aude Ravaud, Alain Cojean-Zelek, Isabelle Oudard, Stéphane Labourey, Jean-Luc Chinet-Charrot, Paule Legouffe, Eric Lagrange, Jean-Léon Linassier, Claude Deplanque, Gaël Beuzeboc, Philippe Davin, Jean-Louis Martin, Anne-Laure Habibian, Muriel Laplanche, Agnès Culine, Stéphane